is tirzepatide a glp 1 agonist Main physiological actions of the dual GIP and GLP-1 Tirzepatide 10mg — GLP-1/GIP Dual-Agonist

[2] Liraglutide (Saxenda) is indicated in combination with a reduced calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in people aged twelve years of age and older with body weight greater than 60 kilograms (130 lb) and obesity

In clinical trials, individuals using semaglutide GLP-1 for weight loss experienced noticeable weight reduction within the first few weeks of treatment

May help regulate blood pressure levels

Personalized Dosing: When Genetic Testing Informs Your Treatment Plan The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways

By emphasizing the need for advanced research methodologies, personalized treatment strategies, and comprehensive clinical trials, we offer a nuanced framework for translating EGCGs promising neuroprotective potential into practical, targeted therapeutic applications